MODALTIN Trademark

Trademark Overview


On Monday, May 23, 2022, a trademark application was filed for MODALTIN with the United States Patent and Trademark Office. The USPTO has given the MODALTIN trademark a serial number of 97424052. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by TONIX PHARMACEUTICALS, INC.. The MODALTIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders
modaltin

General Information


Serial Number97424052
Word MarkMODALTIN
Filing DateMonday, May 23, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, addiction, alcoholism, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTONIX PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChatham, NJ 07928

Party NameTONIX PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Thursday, May 26, 2022NEW APPLICATION ENTERED
Thursday, May 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 26, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 1 FILED
Monday, June 26, 2023SOU EXTENSION 1 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 22, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 22, 2023SOU EXTENSION 2 FILED
Friday, December 22, 2023SOU EXTENSION 2 GRANTED
Tuesday, December 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024SOU EXTENSION 3 FILED